ATRX mutations frequently co‐occur with TP53 mutations, promoting tumor proliferation by activating the alternative lengthening of telomeres mechanism, and are closely associated with IDH‐mutant gliomas [36]. Here, IDH1 is linked to central nervous system cancer.